Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 9—September 2013

CME ACTIVITY

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

Amy Parker FiebelkornComments to Author , Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
Author affiliations: Centers for Disease Control and Prevention, Atlanta, GA, USA (A. Parker Fiebelkorn, A.T. Curns, G.S. Wallace); Orange County Health Department, Goshen, New York, USA (J. Lawler, C. Brandeburg)

Main Article

Table 1

Characteristics of index case-patients with mumps, Orange County, New York, 2009–2010*

Characteristic No. (%)
Age. y
Median (range) 9 (1–39)
0–3 3 (6.1)
4–6 8 (16.3)
7–17 27 (55.1)
>18
11 (22.4)
Sex
F 24 (49.0)
M
25 (51.0)
No. MMR doses
0 11 (22.4)
1 5 (10.2)
2 32 (65.3)
3 1 (2.0)†
>1 38 (77.6)
Median interval (range) since last dose, mo 47 (3–170)

*MMR, measles-mumps-rubella vaccine; values are in no. (%) unless otherwise indicated.
†Person received a third MMR does in January 2010 prior to parotitis onset in February 2010. This person did not receive the third dose as part of the study.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO